Clonazepam Orally Disintegrating Tablets Recall
November 22, 2024
On Nov. 19, 2024, Endo Pharmaceuticals, the parent company of Par Pharmaceuticals, notified the FDA of an expansion of its voluntary recall of Clonazepam Orally Disintegrating Tablets